JP2008513370A5 - - Google Patents

Download PDF

Info

Publication number
JP2008513370A5
JP2008513370A5 JP2007531465A JP2007531465A JP2008513370A5 JP 2008513370 A5 JP2008513370 A5 JP 2008513370A5 JP 2007531465 A JP2007531465 A JP 2007531465A JP 2007531465 A JP2007531465 A JP 2007531465A JP 2008513370 A5 JP2008513370 A5 JP 2008513370A5
Authority
JP
Japan
Prior art keywords
composition
alkyl
disorder
compound
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007531465A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008513370A (ja
Filing date
Publication date
Priority claimed from US10/940,269 external-priority patent/US20050209300A1/en
Priority claimed from US11/077,664 external-priority patent/US20060074124A1/en
Application filed filed Critical
Publication of JP2008513370A publication Critical patent/JP2008513370A/ja
Publication of JP2008513370A5 publication Critical patent/JP2008513370A5/ja
Pending legal-status Critical Current

Links

JP2007531465A 2004-09-13 2005-09-13 障害を処置する方法 Pending JP2008513370A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/940,269 US20050209300A1 (en) 2003-09-12 2004-09-13 Methods of treating a disorder
US11/077,664 US20060074124A1 (en) 2003-09-12 2005-03-11 Methods of treating a disorder
PCT/US2005/032760 WO2006031894A2 (en) 2004-09-13 2005-09-13 Methods of treating a disorder

Publications (2)

Publication Number Publication Date
JP2008513370A JP2008513370A (ja) 2008-05-01
JP2008513370A5 true JP2008513370A5 (enExample) 2008-09-18

Family

ID=36060677

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007531465A Pending JP2008513370A (ja) 2004-09-13 2005-09-13 障害を処置する方法

Country Status (7)

Country Link
US (4) US20060074124A1 (enExample)
EP (1) EP1793817A4 (enExample)
JP (1) JP2008513370A (enExample)
AU (1) AU2005284851A1 (enExample)
CA (1) CA2578355A1 (enExample)
MX (1) MX2007002816A (enExample)
WO (1) WO2006031894A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060074124A1 (en) 2003-09-12 2006-04-06 Andrew Napper Methods of treating a disorder
US20090022694A1 (en) * 2005-10-18 2009-01-22 Distefano Peter Sirt1 inhibition
CA2667826C (en) 2006-10-28 2013-10-08 Methylgene Inc. Inhibitors of histone deacetylase
WO2008054767A2 (en) * 2006-10-30 2008-05-08 University Of Southern California N4 modifications of pyrimidine analogs and uses thereof
WO2008060400A2 (en) * 2006-11-15 2008-05-22 Sirtris Pharmaceuticals, Inc. Sirtuin polymorphisms and methods of use thereof
UA98777C2 (en) * 2006-11-20 2012-06-25 Эли Лилли Энд Компани Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators
EP2102230A2 (en) * 2006-12-29 2009-09-23 Gloucester Pharmaceuticals, Inc. Purifiction of romidepsin
CN103497238A (zh) * 2006-12-29 2014-01-08 细胞基因公司 制备Romidepsin
WO2008119070A1 (en) * 2007-03-28 2008-10-02 Trustees Of Boston University Methods of treatment using sirt modulators and compositions containing sirt1 modulators
EA019713B1 (ru) * 2008-05-16 2014-05-30 Эли Лилли Энд Компани ТЕТРАГИДРОЦИКЛОПЕНТА[b]ИНДОЛЬНЫЕ МОДУЛЯТОРЫ РЕЦЕПТОРОВ АНДРОГЕНОВ
EP2367563A4 (en) 2008-12-08 2012-12-19 Univ Northwestern PROCESS FOR HSF-1 MODULATION
US8318928B2 (en) * 2008-12-15 2012-11-27 Glenmark Pharmaceuticals, S.A. Fused imidazole carboxamides as TRPV3 modulators
JP2012076998A (ja) * 2009-01-29 2012-04-19 Sapporo Medical Univ メラノーマの転移抑制剤
BRPI1014821A2 (pt) * 2009-04-09 2016-04-05 Boehringer Ingelheim Int "inibidores de replicação de hiv"
EA026134B1 (ru) 2010-12-16 2017-03-31 Ф. Хоффманн-Ля Рош Аг Трициклические ингибиторы pi3k и способы их применения
AR088377A1 (es) * 2011-10-20 2014-05-28 Siena Biotech Spa Proceso para la preparacion de 6-cloro-2,3,4,9-tetrahidro-1h-carbazol-1-carboxamida y compuestos intermedios de esta
US10100331B2 (en) * 2012-10-29 2018-10-16 Agency For Science, Technology And Research Reagent for gene-drug therapeutics
CA2968884A1 (en) 2014-12-10 2016-06-16 Massachusetts Institute Of Technology Fused 1,3-azole derivatives useful for the treatment of proliferative diseases
US9745253B2 (en) 2015-03-13 2017-08-29 Forma Therapeutics, Inc. Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
RU2018132559A (ru) 2016-02-16 2020-03-17 Массачусетс Инститьют Оф Текнолоджи Связывающие молекулы для max в качестве модуляторов myc и их применения
WO2018236910A1 (en) * 2017-06-19 2018-12-27 The Board Of Trustees Of The Leland Stanford Junior University Compounds for the reduction of the deleterious activity of extended nucleotide repeat containing genes
WO2020083933A1 (en) * 2018-10-23 2020-04-30 Mexav Biotech Ag Fusion polypeptides and therapeutic applications thereof
PY2438446A (es) * 2023-05-16 2025-06-18 Aop Orphan Ip Ag Preparación de (s)-6-cloro-2,3,4,9- tetrahidro-1h-carbazol-1-carboxamida en forma enantioméricamente enriquecida mediante proceso de resolución
CN120118019A (zh) * 2023-12-08 2025-06-10 苏州湃芮生物科技有限公司 一种RNA m6A调控剂的共晶形式及其制备方法与应用
CN120136769A (zh) * 2023-12-11 2025-06-13 苏州湃芮生物科技有限公司 一种RNA m6A调控剂的结晶形式及其制备方法与应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3769298A (en) * 1971-04-02 1973-10-30 Pfizer Substituted aminomethylcarbazoles
BE793493A (fr) * 1971-12-30 1973-06-29 Hoffmann La Roche Composes tricycliques
DE2226703A1 (de) * 1972-05-25 1973-12-13 Schering Ag Neue tetrahydrocarbazolderivate und verfahren zu ihrer herstellung
US4009181A (en) * 1973-01-22 1977-02-22 Hoffmann-La Roche Inc. Cyclopenta[b]indole-2-carboxylic acids and derivatives thereof
DE2431292A1 (de) 1974-06-27 1976-01-15 Schering Ag Neue carbazol-derivate
BG25793A3 (bg) * 1973-07-18 1978-12-12 Schering Aktiengesellschaft Метод за получаване на карбазолови деривати
US4057640A (en) 1973-07-18 1977-11-08 Schering Aktiengesellschaft 5,6,7,8:Tetrahydrocarbazole-1-carboxylic acid derivatives
MX9700696A (es) * 1994-07-27 1997-04-30 Sankyo Co Compuestos heterociclicos, utiles como productores de efecto aloesterico en receptores muscarinicos.
KR20000005175A (ko) * 1996-04-04 2000-01-25 프리돌린 클라우스너, 롤란드 비. 보레르 테트라하이드로-베타-카르볼린 유도체의 항전이제로서의 용도
US5830911A (en) * 1996-08-14 1998-11-03 American Home Products Corporation Pyranoindole and tetrahydrocarbazole inhibitors of COX-2
WO2000002878A1 (en) * 1998-07-11 2000-01-20 University Of Bristol Compounds having activity at imidazoline receptors
US20010039012A1 (en) * 1999-06-14 2001-11-08 Lapidus Stanley N. Methods for diagnostic screening
WO2002102981A2 (en) 2001-06-15 2002-12-27 The Trustees Of Columbia University In The City Of New York SIR2α-BASED THERAPEUTIC AND PROPHYLACTIC METHODS
JP2005518375A (ja) * 2001-12-14 2005-06-23 ツェンタリス ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｇタンパク質結合受容体（ｇｐｃｒ）のためのリガンドとしてのテトラヒドロカルバゾール誘導体
CA2473740A1 (en) * 2002-01-18 2003-07-31 David Solow-Cordero Methods of treating conditions associated with an edg receptor
CA2509607A1 (en) * 2002-12-13 2004-07-01 Elixir Pharmaceuticals, Inc. Cytochrome c acetylation
US20050137220A1 (en) * 2003-07-23 2005-06-23 Pharmacia Corporation Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
US20060074124A1 (en) * 2003-09-12 2006-04-06 Andrew Napper Methods of treating a disorder
WO2005026112A2 (en) * 2003-09-12 2005-03-24 Elixir Pharmaceuticals, Inc. Methods of treating a disorder
EP1694323A4 (en) * 2003-12-19 2009-05-13 Elixir Pharmaceuticals Inc METHOD FOR TREATING A DISEASE
CA2553814A1 (en) * 2004-01-29 2005-08-11 Elixir Pharmaceuticals, Inc. Treating a viral disorder

Similar Documents

Publication Publication Date Title
JP2007505148A5 (enExample)
JP2007515429A5 (enExample)
RU2443691C2 (ru) Мочевинные активаторы глюкокиназы
JP2009530399A5 (enExample)
JP2009529541A5 (enExample)
JP2004523582A5 (enExample)
EP2371811A3 (en) Azetidinecarboxylic acid derivative and medicinal use thereof
JP2009514837A5 (enExample)
JP2012530779A5 (enExample)
JP2010514829A5 (enExample)
JP2010526145A5 (enExample)
JP2011527333A5 (enExample)
MX2007010532A (es) Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii.
MY156747A (en) Isoxazolo-pyridine derivatives
JP2008521829A5 (enExample)
JP2020502092A5 (enExample)
JP2012508734A5 (enExample)
JP2010514758A5 (enExample)
JP2018530582A5 (enExample)
RU2010107169A (ru) Фармацевтическая композиция, содержащая оптически активное соединение, обладающее активностью агониста рецептора тромбопоэтина, и промежуточное соединение для этого
JP2005539045A5 (enExample)
RU2010127297A (ru) 5-галогензамещенные производные оксиндола и их применение для лечения вазопрессинзависимых заболеваний
WO2008088039A1 (ja) ドネペジルを含有する安定化医薬組成物、その製造方法、及び安定化方法
EA016687B8 (ru) Производные циклопропиламида
US20090062263A1 (en) 4-Hydroxy-5,6-dihydro-1H-pyridin-2-one compounds